Screening Research

John Neate, Chief Executive at The Prostate Cancer Charity, spoke to BBC News Online about the findings of a joint study carried out by the Institute of Cancer Research and the Royal Marsden Hospital, which suggested that screening men at an increased genetic risk of developing prostate cancer could be beneficial.

Whilst potentially significant, John urged caution as data shared are preliminary results from a long-term study which will take many years to complete. John also recommended that the UK National Screening Committee to take the findings into account when assessing the validity of the PSA blood test as a screening tool for prostate cancer.